{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:58:53Z","timestamp":1790380733821,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ege University Scientific Research Projects Coordination Unit","award":["Project No: 22979"],"award-info":[{"award-number":["Project No: 22979"]}],"id":[{"id":"https:\/\/ror.org\/02eaafc18","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12762-2","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:02:36Z","timestamp":1789560156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of a circulating miR-6838-5p\/miR-195-5p signature in invasive ductal breast carcinoma"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5278-549X","authenticated-orcid":false,"given":"Mustafa Bar\u0131\u015f","family":"Zeytunlu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2111-1418","authenticated-orcid":false,"given":"Fazilet Esra Incedere","family":"Duzdag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9004-1794","authenticated-orcid":false,"given":"H\u00fcseyin","family":"Esin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9125-6444","authenticated-orcid":false,"given":"Cagdas","family":"Aktan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1832-1454","authenticated-orcid":false,"given":"Burcin Tezcanli","family":"Kaymaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"12762_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"12762_CR2","unstructured":"Cancer of the Breast (Female) - Cancer Stat Facts. SEER. https:\/\/seer.cancer.gov\/statfacts\/html\/breast.html. Accessed 31 Jan 2026"},{"key":"12762_CR3","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1055\/s-0043-1776716","volume":"45","author":"AVde Andrade","year":"2023","unstructured":"Andrade AVde, Lucena C\u00caMde, Santos DCdos, Pessoa EC, Mansani FP, Andrade FEMde et al (2023) Challenges of breast cancer screening. RBGO Gynecol Obstet 45:622\u2013625. https:\/\/doi.org\/10.1055\/s-0043-1776716","journal-title":"RBGO Gynecol Obstet"},{"key":"12762_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jbi\/wbaf064","volume":"8","author":"Z Kellow","year":"2026","unstructured":"Kellow Z, Kulkarni S, Gordon PB, Seely JM (2026) Canadian Society Breast Imaging Position Statement on Mammographic Breast Density and Supplemental Screening. J Breast Imaging 8:1\u20137. https:\/\/doi.org\/10.1093\/jbi\/wbaf064","journal-title":"J Breast Imaging"},{"key":"12762_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP, MicroRNAs (2004) Genomics, Biogenesis, Mechanism, and Function. Cell 116:281\u2013297. https:\/\/doi.org\/10.1016\/S0092-8674(04)00045-5","journal-title":"Cell"},{"key":"12762_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP, MicroRNAs (2009) Target Recognition and Regulatory Functions. Cell 136:215\u2013233. https:\/\/doi.org\/10.1016\/j.cell.2009.01.002","journal-title":"Cell"},{"key":"12762_CR7","doi-asserted-by":"publisher","unstructured":"Chen M, Calin GA, Meng QH (2014) Chapter Five - Circulating microRNAs as Promising Tumor Biomarkers. In: Makowski GS, editor. Adv Clin Chem. Elsevier; pp. 189\u2013214. https:\/\/doi.org\/10.1016\/bs.acc.2014.09.007","DOI":"10.1016\/bs.acc.2014.09.007"},{"key":"12762_CR8","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","volume":"20","author":"J Hayes","year":"2014","unstructured":"Hayes J, Peruzzi PP, Lawler S (2014) MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med 20:460\u2013469. https:\/\/doi.org\/10.1016\/j.molmed.2014.06.005","journal-title":"Trends Mol Med"},{"key":"12762_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/nrg1379","author":"L He","year":"2004","unstructured":"He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. https:\/\/doi.org\/10.1038\/nrg1379","journal-title":"Nat Rev Genet"},{"key":"12762_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-immunol-020711-075013","volume":"30","author":"RM O\u2019Connell","year":"2012","unstructured":"O\u2019Connell RM, Rao DS, Baltimore D (2012) microRNA Regulation of Inflammatory Responses. Annu Rev Immunol 30:295\u2013312. https:\/\/doi.org\/10.1146\/annurev-immunol-020711-075013","journal-title":"Annu Rev Immunol"},{"key":"12762_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrclinonc.2014.5","volume":"11","author":"H Schwarzenbach","year":"2014","unstructured":"Schwarzenbach H, Nishida N, Calin GA, Pantel K (2014) Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol Nat Publishing Group 11:145\u2013156. https:\/\/doi.org\/10.1038\/nrclinonc.2014.5","journal-title":"Nat Rev Clin Oncol Nat Publishing Group"},{"key":"12762_CR12","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL et al (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105:10513\u201310518. https:\/\/doi.org\/10.1073\/pnas.0804549105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12762_CR13","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1158\/0008-5472.CAN-16-0359","volume":"76","author":"AA Svoronos","year":"2016","unstructured":"Svoronos AA, Engelman DM, Slack FJ (2016) OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer. Cancer Res 76:3666\u20133670. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0359","journal-title":"Cancer Res"},{"issue":"2","key":"12762_CR14","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s13277-014-2700-8","volume":"36","author":"Z Cui","year":"2015","unstructured":"Cui Z, Lin D, Song W, Chen M, Li D (2015) Diagnostic value of circulating microRNAs as biomarkers for breast cancer: a meta-analysis study. Tumour Biol 36(2):829\u2013839. https:\/\/doi.org\/10.1007\/s13277-014-2700-8","journal-title":"Tumour Biol"},{"key":"12762_CR15","doi-asserted-by":"publisher","first-page":"10432","DOI":"10.3748\/wjg.v20.i30.10432","volume":"20","author":"VY Shin","year":"2014","unstructured":"Shin VY, Chu K-M (2014) MiRNA as potential biomarkers and therapeutic targets for gastric cancer. World J Gastroenterol WJG 20:10432\u201310439. https:\/\/doi.org\/10.3748\/wjg.v20.i30.10432","journal-title":"World J Gastroenterol WJG"},{"key":"12762_CR16","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.molonc.2014.02.009","volume":"8","author":"J Jarry","year":"2014","unstructured":"Jarry J, Schadendorf D, Greenwood C, Spatz A, van Kempen LC (2014) The validity of circulating microRNAs in oncology: Five years of challenges and contradictions. Mol Oncol 8:819\u2013829. https:\/\/doi.org\/10.1016\/j.molonc.2014.02.009","journal-title":"Mol Oncol"},{"key":"12762_CR17","doi-asserted-by":"publisher","first-page":"3910","DOI":"10.3390\/ijms24043910","volume":"24","author":"L Padroni","year":"2023","unstructured":"Padroni L, De Marco L, Dansero L, Fiano V, Milani L, Vasapolli P et al (2023) An Epidemiological Systematic Review with Meta-Analysis on Biomarker Role of Circulating MicroRNAs in Breast Cancer Incidence. Int J Mol Sci 24:3910. https:\/\/doi.org\/10.3390\/ijms24043910","journal-title":"Int J Mol Sci"},{"key":"12762_CR18","doi-asserted-by":"publisher","first-page":"731479","DOI":"10.1155\/2015\/731479","volume":"2015","author":"P Tiberio","year":"2015","unstructured":"Tiberio P, Callari M, Angeloni V, Daidone MG, Appierto V (2015) Challenges in Using Circulating miRNAs as Cancer Biomarkers. BioMed Res Int 2015:731479. https:\/\/doi.org\/10.1155\/2015\/731479","journal-title":"BioMed Res Int"},{"key":"12762_CR19","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3389\/fgene.2019.00626","volume":"10","author":"M Cui","year":"2019","unstructured":"Cui M, Wang H, Yao X, Zhang D, Xie Y, Cui R et al (2019) Circulating MicroRNAs in Cancer: Potential and Challenge. Front Genet 10:626. https:\/\/doi.org\/10.3389\/fgene.2019.00626","journal-title":"Front Genet"},{"key":"12762_CR20","unstructured":"PDQ Adult Treatment Editorial Board. Breast Cancer Treatment (PDQ\u00ae): Health Professional Version. PDQ Cancer Inf Summ. Bethesda (MD): National Cancer Institute (US) (2002). http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK65744\/. Accessed 20 June 2026"},{"key":"12762_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang A-G, Buchner A (2007) G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175\u2013191. https:\/\/doi.org\/10.3758\/BF03193146","journal-title":"Behav Res Methods"},{"key":"12762_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/2049-1891-3-4","volume":"3","author":"K Kang","year":"2012","unstructured":"Kang K, Peng X, Luo J, Gou D (2012) Identification of circulating miRNA biomarkers based on global quantitative real-time PCR profiling. J Anim Sci Biotechnol 3:4. https:\/\/doi.org\/10.1186\/2049-1891-3-4","journal-title":"J Anim Sci Biotechnol"},{"key":"12762_CR23","doi-asserted-by":"publisher","first-page":"R64","DOI":"10.1186\/gb-2009-10-6-r64","volume":"10","author":"P Mestdagh","year":"2009","unstructured":"Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, Speleman F et al (2009) A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 10:R64. https:\/\/doi.org\/10.1186\/gb-2009-10-6-r64","journal-title":"Genome Biol"},{"key":"12762_CR24","doi-asserted-by":"publisher","unstructured":"Agarwal V, Bell GW, Nam J-W, Bartel DP Predicting effective microRNA target sites in mammalian mRNAs. eLife ;4:e05005. https:\/\/doi.org\/10.7554\/eLife.05005","DOI":"10.7554\/eLife.05005"},{"key":"12762_CR25","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X (2020) miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res 48:D127\u2013D131. https:\/\/doi.org\/10.1093\/nar\/gkz757","journal-title":"Nucleic Acids Res"},{"key":"12762_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13059-019-1629-z","volume":"20","author":"W Liu","year":"2019","unstructured":"Liu W, Wang X (2019) Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data. Genome Biol 20:18. https:\/\/doi.org\/10.1186\/s13059-019-1629-z","journal-title":"Genome Biol"},{"key":"12762_CR27","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/cas.12880","volume":"107","author":"A Shimomura","year":"2016","unstructured":"Shimomura A, Shiino S, Kawauchi J, Takizawa S, Sakamoto H, Matsuzaki J et al (2016) Novel combination of serum microRNA for detecting breast cancer in the early stage. Cancer Sci 107:326\u2013334. https:\/\/doi.org\/10.1111\/cas.12880","journal-title":"Cancer Sci"},{"key":"12762_CR28","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","volume":"123","author":"B Gy\u00f6rffy","year":"2010","unstructured":"Gy\u00f6rffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q et al (2010) An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat 123:725\u2013731. https:\/\/doi.org\/10.1007\/s10549-009-0674-9","journal-title":"Breast Cancer Res Treat"},{"key":"12762_CR29","doi-asserted-by":"publisher","first-page":"e27633","DOI":"10.2196\/27633","volume-title":"Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation. J Med Internet Res","author":"A L\u00e1nczky","year":"2021","unstructured":"L\u00e1nczky A, Gy\u0151rffy B (2021) Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation. J Med Internet Res, vol 23. JMIR Publications Inc., Toronto, Canada, p e27633. https:\/\/doi.org\/10.2196\/27633"},{"key":"12762_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"The Cancer Genome Atlas Network","year":"2012","unstructured":"The Cancer Genome Atlas Network (2012) Comprehensive molecular portraits of human breast tumours. Nature 490:61\u201370. https:\/\/doi.org\/10.1038\/nature11412","journal-title":"Nature"},{"key":"12762_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C et al (2011) pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinformatics 12:77. https:\/\/doi.org\/10.1186\/1471-2105-12-77","journal-title":"BMC Bioinformatics"},{"key":"12762_CR32","unstructured":"CRAN (2026) Manuals. https:\/\/cran.r-project.org\/manuals.html. Accessed 30 Jan"},{"key":"12762_CR33","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10549-006-9253-5","volume":"100","author":"DF Hayes","year":"2006","unstructured":"Hayes DF, Ethier S, Lippman ME (2006) New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK. Breast Cancer Res Treat 100:237\u2013238. https:\/\/doi.org\/10.1007\/s10549-006-9253-5","journal-title":"Breast Cancer Res Treat"},{"key":"12762_CR34","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/jnci\/dji237","volume":"97","author":"LM McShane","year":"2005","unstructured":"McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2005) Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK). JNCI J Natl Cancer Inst 97:1180\u20131184. https:\/\/doi.org\/10.1093\/jnci\/dji237","journal-title":"JNCI J Natl Cancer Inst"},{"key":"12762_CR35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3892\/ol.2016.5452","volume":"13","author":"S Pizzamiglio","year":"2017","unstructured":"Pizzamiglio S, Zanutto S, Ciniselli CM, Belfiore A, Bottelli S, Gariboldi M et al (2017) A methodological procedure for evaluating the impact of hemolysis on circulating microRNAs. Oncol Lett 13:315\u2013320. https:\/\/doi.org\/10.3892\/ol.2016.5452","journal-title":"Oncol Lett"},{"issue":"9","key":"12762_CR36","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/aje\/kwh101","volume":"159","author":"MS Pepe","year":"2004","unstructured":"Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P (2004) Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 159(9):882\u2013890. https:\/\/doi.org\/10.1093\/aje\/kwh101","journal-title":"Am J Epidemiol"},{"key":"12762_CR37","doi-asserted-by":"publisher","first-page":"6253","DOI":"10.3892\/ol.2018.9489","volume":"16","author":"B Liu","year":"2018","unstructured":"Liu B, Liu Y, Luo X, Pan Y, Yang L, Li F et al (2018) MicroRNA-195 as a diagnostic biomarker in human cancer detection: A meta-analysis. Oncol Lett 16:6253\u20136260. https:\/\/doi.org\/10.3892\/ol.2018.9489","journal-title":"Oncol Lett"},{"key":"12762_CR38","first-page":"3982","volume":"12","author":"Y Liu","year":"2019","unstructured":"Liu Y, Tang D, Zheng S, Su R, Tang Y (2019) Serum microRNA-195 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis. Int J Clin Exp Pathol 12:3982\u20133991. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6949784\/","journal-title":"Int J Clin Exp Pathol"},{"key":"12762_CR39","doi-asserted-by":"publisher","unstructured":"Jing Y, Huang X, Wang Y, Wang J, Li Y, Yelihamu D et al (2024) Diagnostic value of 5 miRNAs combined detection for breast cancer. Front Genet Front 15. https:\/\/doi.org\/10.3389\/fgene.2024.1482927","DOI":"10.3389\/fgene.2024.1482927"},{"key":"12762_CR40","doi-asserted-by":"publisher","first-page":"69934","DOI":"10.18632\/oncotarget.19482","volume":"8","author":"A Sueta","year":"2017","unstructured":"Sueta A, Yamamoto Y, Tomiguchi M, Takeshita T, Yamamoto-Ibusuki M, Iwase H (2017) Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence. Oncotarget 8:69934\u201369944. https:\/\/doi.org\/10.18632\/oncotarget.19482","journal-title":"Oncotarget"},{"key":"12762_CR41","doi-asserted-by":"publisher","unstructured":"Liu G, Wang P, Zhang H (2019) MiR-6838-5p suppresses cell metastasis and the EMT process in triple-negative breast cancer by targeting WNT3A to inhibit the Wnt pathway. J Gene Med. John Wiley & Sons, Ltd 21:e3129. https:\/\/doi.org\/10.1002\/jgm.3129","DOI":"10.1002\/jgm.3129"},{"key":"12762_CR42","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.12122\/j.issn.1673-4254.2024.09.07","volume":"44","author":"MiR-6838-5p\u8fc7\u8868\u8fbe\u4e0b\u8c03DDR1\u57fa\u56e0\u8868\u8fbe\u6291\u5236\u4e73\u817a\u764cMCF-7\u7ec6\u80de\u7684\u589e\u6b96","year":"2024","unstructured":"MiR-6838-5p\u8fc7\u8868\u8fbe\u4e0b\u8c03DDR1\u57fa\u56e0\u8868\u8fbe\u6291\u5236\u4e73\u817a\u764cMCF-7\u7ec6\u80de\u7684\u589e\u6b96 (2024) J South Med Univ 44:1677\u20131684. https:\/\/doi.org\/10.12122\/j.issn.1673-4254.2024.09.07","journal-title":"J South Med Univ"},{"key":"12762_CR43","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s00432-025-06195-w","volume":"151","author":"S Xu","year":"2025","unstructured":"Xu S, He L, Chen Y, Lin T, Tang L, Wu Y et al (2025) Clinical implications of miR-195 in cancer: mechanisms, potential applications, and therapeutic strategies. J Cancer Res Clin Oncol 151:148. https:\/\/doi.org\/10.1007\/s00432-025-06195-w","journal-title":"J Cancer Res Clin Oncol"},{"key":"12762_CR44","doi-asserted-by":"publisher","first-page":"e13515","DOI":"10.1371\/journal.pone.0013515","volume":"5","author":"L Pigati","year":"2010","unstructured":"Pigati L, Yaddanapudi SCS, Iyengar R, Kim D-J, Hearn SA, Danforth D et al (2010) Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells. PLoS ONE 5:e13515. https:\/\/doi.org\/10.1371\/journal.pone.0013515","journal-title":"PLoS ONE"},{"key":"12762_CR45","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/s41388-024-03076-3","volume":"43","author":"GAD Metcalf","year":"2024","unstructured":"Metcalf GAD (2024) MicroRNAs: circulating biomarkers for the early detection of imperceptible cancers via biosensor and machine-learning advances. Oncogene 43:2135\u20132142. https:\/\/doi.org\/10.1038\/s41388-024-03076-3","journal-title":"Oncogene"},{"key":"12762_CR46","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/sj.bjc.6603023","volume":"94","author":"H-W Hwang","year":"2006","unstructured":"Hwang H-W, Mendell JT (2006) MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 94:776\u2013780. https:\/\/doi.org\/10.1038\/sj.bjc.6603023","journal-title":"Br J Cancer"},{"key":"12762_CR47","doi-asserted-by":"publisher","first-page":"6609","DOI":"10.1128\/MCB.00398-08","volume":"28","author":"A Barroso-delJesus","year":"2008","unstructured":"Barroso-delJesus A, Romero-L\u00f3pez C, Lucena-Aguilar G, Melen GJ, Sanchez L, Ligero G et al (2008) Embryonic Stem Cell-Specific miR302-367 Cluster: Human Gene Structure and Functional Characterization of Its Core Promoter. Mol Cell Biol Taylor Francis 28:6609\u20136619. https:\/\/doi.org\/10.1128\/MCB.00398-08","journal-title":"Mol Cell Biol Taylor Francis"},{"key":"12762_CR48","doi-asserted-by":"publisher","first-page":"6426","DOI":"10.1128\/MCB.00359-08","volume":"28","author":"DA Greer Card","year":"2008","unstructured":"Greer Card DA, Hebbar PB, Li L, Trotter KW, Komatsu Y, Mishina Y et al (2008) Oct4\/Sox2-Regulated miR-302 Targets Cyclin D1 in Human Embryonic Stem Cells. Mol Cell Biol 28:6426\u20136438. https:\/\/doi.org\/10.1128\/MCB.00359-08","journal-title":"Mol Cell Biol"},{"key":"12762_CR49","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/cas.14317","volume":"111","author":"J Liu","year":"2020","unstructured":"Liu J, Wang Y, Ji P, Jin X (2020) Application of the microRNA-302\/367 cluster in cancer therapy. Cancer Sci 111:1065\u20131075. https:\/\/doi.org\/10.1111\/cas.14317","journal-title":"Cancer Sci"},{"key":"12762_CR50","first-page":"146","volume":"9","author":"J Li","year":"2017","unstructured":"Li J, Wei J, Mei Z, Yin Y, Li Y, Lu M et al (2017) Suppressing role of miR-520a-3p in breast cancer through CCND1 and CD44. Am J Transl Res 9:146\u2013154. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5250711\/","journal-title":"Am J Transl Res"},{"key":"12762_CR51","first-page":"1097","volume":"10","author":"Z Ren","year":"2018","unstructured":"Ren Z, Yang T, Ding J, Liu W, Meng X, Zhang P et al (2018) MiR-520d-3p antitumor activity in human breast cancer via post-transcriptional regulation of spindle and kinetochore associated 2 expression. Am J Transl Res 10:1097\u20131108. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5934569\/","journal-title":"Am J Transl Res"},{"key":"12762_CR52","first-page":"562","volume":"53","author":"H Zhang","year":"2023","unstructured":"Zhang H, Zheng Y, Yu L, Liu M, Zhang Y (2023) Identification of circ_0038632 as a Promoter of Breast Cancer through miR-520a-3p-Dependent Modulation of CDCA3. Ann Clin Lab Sci Association Clin Scientists 53:562\u2013572. http:\/\/www.annclinlabsci.org\/content\/53\/4\/562","journal-title":"Ann Clin Lab Sci Association Clin Scientists"},{"issue":"4","key":"12762_CR53","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/PAI.0000000000001190","volume":"32","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Liang S, Zhang Z (2024) Correlation Between miR-497-5p Expression With Clinicopathological Characteristics and Prognosis in Patients With. Breast Cancer Appl Immunohistochem Mol Morphology 32(4):200\u2013205. https:\/\/doi.org\/10.1097\/PAI.0000000000001190","journal-title":"Breast Cancer Appl Immunohistochem Mol Morphology"},{"key":"12762_CR54","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3389\/fonc.2020.00108","volume":"10","author":"B Wu","year":"2020","unstructured":"Wu B, Liu G, Jin Y, Yang T, Zhang D, Ding L et al (2020) miR-15b-5p Promotes Growth and Metastasis in Breast Cancer by Targeting HPSE2. Front Oncol 10:108. https:\/\/doi.org\/10.3389\/fonc.2020.00108","journal-title":"Front Oncol"},{"key":"12762_CR55","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.3390\/genes12081206","volume":"12","author":"MA Shadbad","year":"2021","unstructured":"Shadbad MA, Safaei S, Brunetti O, Derakhshani A, Lotfinejad P, Mokhtarzadeh A et al (2021) A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery. Genes 12:1206. https:\/\/doi.org\/10.3390\/genes12081206","journal-title":"Genes"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12762-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12762-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12762-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:02:29Z","timestamp":1790377349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12762-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12762"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12762-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"9 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Funding section has been updated","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human participants were conducted in accordance with the ethical standards of the institutional and national research committees and with the principles of the Declaration of Helsinki and its subsequent amendments. This study was approved by the Ege University Faculty of Medicine Ethics Committee (Approval No: E.209614). Written informed consent was obtained from all participants prior to enrollment.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the data and results presented in this study.","order":4,"name":"Ethics","label":"Consent to Publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1584"}}